Site notifications

Sub menu

 

 

(Approval lapsed) RITALIN LA methylphenidate hydrochloride 20mg capsules (Switzerland)

Section 19A approved medicine
(Approval lapsed) RITALIN LA methylphenidate hydrochloride 20mg capsules (Switzerland)
Section 19A approval holder
Phero Pharma Pty Ltd ABN 96 673 730 231
Phone
02 9420 9199
Approved until
Status
Expired
Medicines in short supply/unavailable
RITALIN LA methylphenidate hydrochloride 20 mg modified release capsule bottle - ARTG 82957
RUBIFEN LA methylphenidate hydrochloride 20 mg modified release capsules blister pack - ARTG 362231
Indication(s)

Methylphenidate hydrochloride modified release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and children aged 6 years and over.

Related medicines shortage notifications
https://apps.tga.gov.au/Prod/msi/Search/Details/methylphenidate-hydrochloride
Images
Picture of RITALIN LA methylphenidate hydrochloride 20mg capsules - carton